Abstract
Objective
To determine mortality and factors that might predict outcome in severe community-acquired pneumococcal pneumonia treated by a standard protocol.
Design
Prospective, nonconcurrent study.
Setting
Respiratory intensive care unit (ICU) in a teaching hospital by positive blood culture.
Patients
63 patients who were diagnosed by positive blood culture or Gram stain and culture of sputum or tracheal aspirate were included.
Measurements and results
Clinical features, severity scores including Acute Physiology and Chronic Health Evaluation (APACHE) II, organ failure and lung injury scores, and the clinical course in the ICU were documented; 79% of patients required mechanical ventilation. Bacteraemia was present in 34 patients (54%); there were no distinguishing clinical features between bacteraemic and non-bacteraemic cases. The overall mortality was 21%, with only 5 deaths (15% mortality) in the bacteraemic group. Shock and a very low serum albumin (<26 g/l) were the only clinical features that differentiated survivors from non-survivors; lung injury, APACHE II and multiple organ failure scores were all predictive of outcome. The positive predictive value and specificity in predicting death in individuals for the modified British Thoracic Society rule 1 were 26 and 64%; APACHE II>20 57 and 88%; >2 organ failure 64 and 92%; and lung injury >2 33 and 73%, respectively.
Conclusions
These results suggest that even in bacteraemic cases mortality should be below 25% with intensive care management and that conventional scoring systems, while predictive of group mortality, are unreliable in individuals.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Prout S, Potgieter PD, Forder AA, Moodie JW, Matthews J (1983) Acute community-acquired pneumonias. S Afr Med J 64: 443–446
Marrie TJ (1994) Community-acquired pneumonia. Clin Infect Dis 18: 501–513
Macfarlane JT, Finch RG, Ward MJ, Macrae AD (1982) Hospital study of adult community-acquired pneumonia. Lancet J I: 255–258
Ortqvist A, Sterner G, Nilsson A (1985) Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis. Scand J Infect Dis 17: 377–386
Austrian R (1986) Pneumococcal pneumonia. Diagnostic, epidemiologic, therapeutic and prophylactic considerations. Chest 90: 738–743
Kramer MR, Rudensky B, Haddas-Halperin I, Isacsohn M, Melzer E (1987) Pneumococcal bacteraemia: no change in mortality over 30 years-analysis of 104 cases and review of the literature. Isr J Med Sci 23: 174–180
Hook EW, Horton CA, Schaberg DR (1983) Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA 249: 1055–1057
Banks RA, George RC, McNicol MW (1984) Pneumococcal pneumonia with bacteraemia. Respir Med 78: 352–357
Ortqvist A, Kalin M, Julander I, Mufson MA (1993) Deaths in bacteremic pneumococcal pneumonia. Chest 103: 710–716
Breiman RF, Spika JS, Navarro VJ, Darden PM, Darby CP (1990) Pneumococcal bacteremia in Charleston County, South Carolina: a decade later. Arch Intern Med 150: 1401–1405
Pesola GR, Allison C (1992) Pneumococcal Bacteremia with pneumonia. Mortality in acquired immunodeficiency syndrome. Chest 101: 150–155
Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE 2: a severity of disease classification system. Crit Care Med 13: 818–829
Murray JF, Matthay MA, Luce JM, Flick MR (1988) An expanded definition of the adult respiratory distress syndrome. Am J Respir Crit Care Med 138: 720–723
Andrews BE, Bartlett CLR, Connolly CK, Ellis DA, Farr BM, Harrison BDW (1987) Community-acquired pneumonia in adults in British hospitals in 1982–1983: a survey of aetiology, mortality, prognostic factors and outcome. Q J Med 62: 195–220
Knaus WA, Draper EA, Wagner DP (1985) Prognosis in acute organ system failure. Ann Surg 202: 685–690
Sorensen J, Forsberg P, Hakason E, Maller R, Sederholm C, Soren L, Carlsson C (1989) A new diagnostic approach to the patient with severe pneumonia. Scand J Infect Dis 21: 33–41
Torres A, Serra-Batlles J, Ferrer A, Jimenez P, Celis R, Cobo E, Rodiriguez-Roisin R (1991) Severe community-acquired pneumonia. Am J Respir Crit Care Med 144: 312–318
Marrie TJ (1992) Bacteraemic pneumococcal pneumonia: a continuously evolving disease. J Infect 24: 247–256
Bruyn GAW, van der Meer JWM, Hermans J, Knoppert W (1988) Pneumococcal bacteraemia over a 10-year period at University Hospital, Leiden. Rev Infect Dis 10: 446–450
Brett A, Sinclair DG (1993) Use of continuous positive airway pressure in the management of community acquired pneumonia. Thorax 48: 1280–1281
Tuxen DV (1994) Permissive hypercapnic ventilation. Am J Respir Crit Care Med 150: 870–874
Marini JJ (1994) Pressure-targeted, lung-protective ventilatory support in acute lung injury. Chest 105: 109S-115S
Pallares R, Linares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, Martin R, Gudiol F (1995) Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 333: 474–480
Hofmann J, Cetron MS, Farley MM, Baughman WS, Facklam RR, Elliott JA, Deaver KA, Breiman RF (1995) The prevalence of drug-resistantStreptococcus pneumoniae in Atlanta. N Engl J Med 333: 481–486
Pittet D, Thie'vent B, Wenzel RP, Ning L, Auckenthaler R, Suter P (1996) Bedside prediction of mortality from bacteremic sepsis. Am J Respir Crit Care Med 153: 684–693
Kuikka A, Syrjanen J, Renkonen OV, Valtonen VV (1992) Pneumococcal bacteraemia during a recent decade. J Infect 24: 157–168
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Potgieter, P.D., Hammond, J.M.J. The intensive care management, mortality and prognostic indicators in severe community-acquired pneumococcal pneumonia. Intensive Care Med 22, 1301–1306 (1996). https://doi.org/10.1007/BF01709542
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01709542